Moral Berrio, E.; De La Flor, J.C.; Arambarri Segura, M.; Rodríguez-Doyágüez, P.; Martínez Calero, A.; Zamora, R.; Cieza-Terrones, M.; Yuste-Lozano, C.; Sánchez de la Nieta García, M.D.; Nieto Iglesias, J.;
et al. Effects of Sodium–Glucose Cotransporter 2 Inhibitors in Diabetic and Non-Diabetic Patients with Advanced Chronic Kidney Disease in Peritoneal Dialysis on Residual Kidney Function: In Real-World Data. Medicina 2024, 60, 1198.
https://doi.org/10.3390/medicina60081198
AMA Style
Moral Berrio E, De La Flor JC, Arambarri Segura M, Rodríguez-Doyágüez P, Martínez Calero A, Zamora R, Cieza-Terrones M, Yuste-Lozano C, Sánchez de la Nieta García MD, Nieto Iglesias J,
et al. Effects of Sodium–Glucose Cotransporter 2 Inhibitors in Diabetic and Non-Diabetic Patients with Advanced Chronic Kidney Disease in Peritoneal Dialysis on Residual Kidney Function: In Real-World Data. Medicina. 2024; 60(8):1198.
https://doi.org/10.3390/medicina60081198
Chicago/Turabian Style
Moral Berrio, Esperanza, José C. De La Flor, Minerva Arambarri Segura, Pablo Rodríguez-Doyágüez, Alberto Martínez Calero, Rocío Zamora, Michael Cieza-Terrones, Claudia Yuste-Lozano, María Dolores Sánchez de la Nieta García, Javier Nieto Iglesias,
and et al. 2024. "Effects of Sodium–Glucose Cotransporter 2 Inhibitors in Diabetic and Non-Diabetic Patients with Advanced Chronic Kidney Disease in Peritoneal Dialysis on Residual Kidney Function: In Real-World Data" Medicina 60, no. 8: 1198.
https://doi.org/10.3390/medicina60081198
APA Style
Moral Berrio, E., De La Flor, J. C., Arambarri Segura, M., Rodríguez-Doyágüez, P., Martínez Calero, A., Zamora, R., Cieza-Terrones, M., Yuste-Lozano, C., Sánchez de la Nieta García, M. D., Nieto Iglesias, J., & Vozmediano Poyatos, C.
(2024). Effects of Sodium–Glucose Cotransporter 2 Inhibitors in Diabetic and Non-Diabetic Patients with Advanced Chronic Kidney Disease in Peritoneal Dialysis on Residual Kidney Function: In Real-World Data. Medicina, 60(8), 1198.
https://doi.org/10.3390/medicina60081198
